RSS-Feed abonnieren
DOI: 10.1055/s-2005-922747
Design and Synthesis of Novel Trichloromethylated N-Azolylmethyl-1H-pyrimidin-2-ones and Related N-Methylenaminones
Publikationsverlauf
Publikationsdatum:
28. November 2005 (online)
Abstract
Reaction of 4-trichloromethyl-1H-pyrimidin-2-ones with 5-bromo-1,1,1-trichloro(fluoro)-4-methoxy-alk-3-en-2-ones affords 1-[5,5,5-trichloro(fluoro)-2-methoxy-4-oxopent-2-en-1-yl]-4-trichloromethyl-1H-pyrimidin-2-ones. Reaction of the latter trichloromethylated compound with amines, hydroxylamine, and hydrazines affords a series of 1-(2-alkylamine-5,5,5-trichloro-4-oxopent-2-en-1-yl)-4-trichloromethyl-1H-pyrimidin-2-ones and 1-(5-trichloromethyl-5-hydroxy-4,5-dihydro-3-azol-3-ylmethyl)-4-trichloromethyl-1H-pyrimidin-2-ones, respectively.
Key words
N-pyrazolylmethylpyrimidinones - pyrimidines - pyrazoles - enamino ketones - halogenated heterocycles
- 1
Ikeda M.Maruyama K.Nobuhara Y.Yamada T.Okabe S. Chem. Pharm. Bull. 1996, 44: 1700 - 2
Ikeda M.Maruyama K.Nobuhara Y.Yamada T.Okabe S. Chem. Pharm. Bull. 1997, 45: 549 - 3
Sedereviciute V.Garaliene V.Vainilavicius P.Hetzheim A. Pharmazie 1998, 53: 233 - 4
Badawey E.-SAM.El-Ashmawey IM. Eur. J. Med. Chem. 1998, 349 - 5
Bonacorso HG.Wentz AP.Zanatta N.Martins MAP. Synthesis 2001, 1505 - 6
Zanatta N.Flores DC.Madruga CC.Faoro D.Flores AFC.Bonacorso HG.Martins MAP. Synthesis 2003, 894 -
7a
Oshima Y.Akimoto T.Tsukada W.Yamasaki T.Yamaguchi K.Kojima H. Chem. Pharm. Bull. 1969, 17: 1492 -
7b
Konish K,Kuragano T, andMatsura K. inventors; Jpn. Kokai Tokkyo Koho JP 62 00, 404 [87 00,404]. ; Chem. Abstr. 1987, 106, 171125f -
7c
Konish K.Kuragano T. Nippon Noyaku Gakkaishi 1990, 15: 13 ; Chem. Abstr. 1990, 113, 36297t -
7d
Shirakava K.Tsujikawa T. Takeda Kenkyusho Nempo 1963, 22: 19 ; Chem. Abstr. 1964, 55, 10450 -
7e
Naito T,Oshima Y,Yoshikawa T,Kasahara A,Domori R,Nakai Y, andTsukada W. inventors; S. African Patent 67,04,936. ; Chem. Abstr. 1969, 70, 57876 - 8
Gupta SP.Hansch C.Garg RC.Gao H.Babu MS.Debnath AK. Chem. Rev. 1999, 99: 3525 - 9
De Clerq E. Nat. Rev. Drug Discov. 2002, 1: 13 - 10
Merino P.Franco S.Merchan FL.Tejero T. J. Org. Chem. 2000, 65: 5575 - 11
Filichev VV.Pedersen RB. Tetrahedron 2001, 57: 9163 -
12a
Pan S.Wang G.Schinazi RF.Zhao K. Tetrahedron Lett. 1998, 39: 8191 -
12b
Dalpozzo R.De Nino A.Maiuolo L.Procópio A.De Munno G.Sindona G. Tetrahedron 2001, 57: 4035 -
12c
Colacino E.Converso A.Liguori A.Napoli A.Siciliano C.Sindona G. Tetrahedron 2001, 57: 8551 -
12d
Chiacchio U.Corsaro A.Mates J.Merino P.Piperno A.Rescifina A.Romeo G.Romeo R.Tejero T. Tetrahedron 2003, 59: 4733 - 13
Lee Y.-S.Kim BH. Bioorg. Med. Chem. Lett. 2002, 12: 1395 -
14a
Martins MAP.Sinhorin AP.Rosa A.Flores AFC.Wastowski AD.Pereira CMP.Flores DC.Beck P.Freitag R.Brondani S.Cunico W.Bonacorso HG.Zanatta N. Synthesis 2002, 2353 -
14b
Martins MAP.Sinhorin AP.Zimmermann NEK.Zanatta N.Bonacorso HG.Bastos GP. Synthesis 2001, 1959 -
14c
Gerus IG.Kacharova LM.Vdovenko SI. Synthesis 2000, 431 -
15a
Zanatta N.Squizani AMC.Fantinel L.Nachtigall FM.Bonacorso HG.Martins MAP. Synthesis 2002, 2409 -
15b
Bonacorso HG.Duarte SHG.Zanatta N.Martins MAP. Synthesis 2002, 1037 -
15c
Bonacorso HG.Wentz AP.Bittencourt SRT.Marques LML.Zanatta N.Martins MAP. Synth. Commun. 2002, 32: 335 -
15d
Andrew RJ.Mellor JM. Tetrahedron 2000, 56: 7267 -
15e
Gorbunova MG.Gerus II.Kukhar VP. Synthesis 1999, 738 -
16a
Martins MAP.Flores AFC.Bastos GP.Zanatta N.Bonacorso HG. J. Heterocycl. Chem. 1999, 36: 837 -
16b
Martins MAP.Sinhorin AP.Zimmermann NEK.Zanatta N.Bonacorso HG.Bastos GP. Synthesis 2001, 13: 1959 -
16c
Martins MAP.Freitag R.Flores AFC.Zanatta N. J. Heterocycl. Chem. 1995, 32: 1491 -
16d
Bonacorso HG.Oliveira MR.Wentz AP.Oliveira AB.Hörner M.Zanatta N.Martins MAP. Tetrahedron 1999, 55: 345 -
16e
Zanatta N.Madruga CC.Marisco PC.Flores DC.Bonacorso HG.Martins MAP. J. Heterocycl. Chem. 2000, 37: 1213 -
16f
Zanatta N.Cortelini MF.Carpes MJS.Bonacorso HG.Martins MAP. J. Heterocycl. Chem. 1997, 34: 509 -
16g
Zanatta N.Fagundes M.Hellensohn RM.Martins AP.Bonacorso HG. J. Heterocycl. Chem. 1998, 35: 451 -
17a
Khalafi-Nezhad A.Zarea A.Soltani Rad MN.Mokhtari B.Parhami A. Synthesis 2005, 419 -
17b
Geen GR.Kincey PM.Choudary BM. Tetrahedron Lett. 1992, 33: 4609 - 18
Pan S.Amankulor NM.Zhao K. Tetrahedron 1998, 54: 6587 - 19
Hojo M.Masuda R.Sakaguchi M.Takagawa M. Synthesis 1986, 1016 - 20
Tietze LF.Meier H.Voss E. Synthesis 1988, 274 - 21
Pacholski IL.Blanco I.Zanatta N.Martins MAP. J. Braz. Chem. Soc. 1992, 2: 118 - 22
Martins MAP.Sinhorin AP.Rosa A.Flores AFC.Wastowski AD.Pereira AMP.Flores DC.Beck P.Freitag RA.Brondani S.Cunico W.Bonacorso HG.Zanatta N. Synthesis 2002, 2353 - 25
Bonacorso HG.Bittencourt SRT.Wastowski A.Wentz AP.Zanatta N.Martins MAP. J. Heterocycl. Chem. 1999, 36: 45 -
27a
Martins MAP.Freitag RA.Rosa A.Flores AFC.Zanatta N.Bonacorso HG. J. Heterocycl. Chem. 1999, 36: 217 -
27b
Flores AFC.Martins MAP.Rosa A.Flores DC.Zanatta N.Bonacorso HG. Synth. Commun. 2002, 32: 1585 -
28a
Bonacorso HG.Wastowski AD.Zanatta N.Martins MAP.Naue JA. J. Fluorine Chem. 1998, 92: 23 -
28b
Bonacorso HG.Wastowski AD.Zanatta N.Martins MAP. Synth. Commun. 2000, 30: 1457 -
28c
Bonacorso HG.Oliveira MR.Wentz AP.Wastowiski AD.Oliveira AB.Hörner M.Zanatta N.Martins MAP. Tetrahedron 1999, 55: 345 -
28d
Bonacorso HG.Wastowski AD.Muniz MN.Zanatta N.Martins MAP. Synthesis 2002, 1079
References
Pyrimidine 5 - General Procedure.
A mixture of 3 (3.0 g, 10.12 mmol), pyrimidinone 1 (2.16 g, 10.12 mmol) and K2CO3 (1.4 g, 10.12 mmol) was refluxed in anhyd acetone (30 mL) or anhyd MeCN for compound 2, for 16 h under vigorous stirring. The reaction was carried out in two phases. The crude product, a white solid, precipitated and was collected under vacuum filtration. The white solid was washed with cold distilled H2O (2 × 15 mL), acetone (2 × 10 mL), dried, and recrystallized from CHCl3-MeOH (3:1). White powder, yield 60%; mp 208 °C (decomp.).
IR (KBr): νmax = 1669, 1617, cm-1. 1H NMR (400 MHz, DMSO-d
6): δ (pyrimidinone) = 7.06 (d, 1 H, 3
J
H5-H6 = 7.0 Hz, H-5), 8.50 (d, 1 H, 3
J
H6-H5 = 7.0 Hz, H-6); δ (enone) = 3.82 (s, 3 H, OMe), 5.35 (s, 2 H, CH2), 6.22 (s, 1 H, H-3). 13C NMR (100 MHz, DMSO-d
6): δ (pyrimidinone) = 95.2 (CCl3), 98.3 (C-5), 153.8 (C-2), 153.4 (C-6), 170.8 (C-4); δ (enone) = 51.9 (CH2), 56.0 (OMe), 90.1 (C-3), 96.7 (CCl3), 174.9 (C-2), 179.8 (C-4). Anal. Calcd for C11H8Cl6N2O3 (428.91): C, 30.80; H, 1.88; N, 6.53. Found: C, 30.69; H, 1.94; N, 6.55.
N
-Isoxazolylmethylpyrimidinone 9.
A mixture of 5 (0.5 g, 1.17 mmol), hydroxylamine hydrochloride (0.15 g, 2.12 mmol), pyridine (0.1 mL, 2.12 mmol), and anhyd MeOH (15 mL) was stirred under reflux for 24 h. The solvent was removed under reduced pressure and a yellow oil was obtained. To this oil was added cold H2O (10 mL) and the mixture was stirred for 20 min in order to precipitate the compound 9. The white powder precipitated and was filtrated and dried under vacuum. The product was purified by recrystallization from CHCl3-MeOH (3:1). Yield 80%; mp 229 °C (decomp.). IR (KBr): νmax = 3196, 1638 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ (pyrimidinone) = 7.09 (d, 1 H, 3
J
H5-H6 = 7.0 Hz, H-5), 8.50 (d, 1 H, 3
J
H6-H5 = 7.0 Hz, H-6); δ (isoxazole) = 3.30 (d, 1 H, 2
J
4Hb-4Ha = 19.0 Hz, 4-Hb), 3.70 (d, 1 H, 2
J
4Ha-4Hb = 19.0 Hz, 4-Ha), 4.95 (s, 2 H, CH2), 8.60 (s, 1 H, OH). 13C NMR (100 MHz, DMSO-d
6): δ (pyrimidinone) = 95.3 (CCl3), 99.0 (C-5), 153.3 (C-6), 153.7 (C-2), 170.8 (C-4); δ (isoxazole) = 44.7 (C-4), 46.9 (CH2), 101.4 (CCl3), 111.5 (C-5), 155.7 (C-3). Anal. Calcd for C10H7Cl6N2O3 (429.90): C, 27.94; H, 1.64; N, 9.77. Found: C, 27.87; H, 1.72; N, 9.71.
Selected Spectroscopic Data and Elemental Analysis of 11d.
Yield 70%; mp 139 °C (decomp.). IR (KBr): νmax = 3472, 3405, 1668, 1618 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ (pyrimidinone) = 7.03 (d, 1 H, 3
J
H5-H6 = 7.0 Hz, H-5), 8.47 (d, 1 H, 3
J
H6-H5 = 7.0 Hz, H-6); δ (pyrazole) = 3.47 (d, 1 H, 2
J
4Hb-4Ha = 20.0 Hz, 4-Hb), 3.78 (d, 1 H, 2
J
4Ha-4Hb = 20.0 Hz, 4-Ha), 5.02 (d, 1 H, 2
J = 16.0 Hz, CH2), 5.13 (d, 1 H,
2
J
H-H = 16.0 Hz, CH2), 8.05 (s, 1 H, OH), 8.15 (s, 1 H, CONH2). 13C NMR (100 MHz, DMSO-d
6): δ (pyrimidin-one) = 95.4 (CCl3), 99.1 (C-5), 153.4 (C-2), 152.6 (C-6), 170.7 (C-4); δ (pyrazole) = 47.5 (C-4), 48.5 (CH2), 104.4 (CCl3), 100.6 (C-5), 153.9 (C-3), 157.3 (CONH2). Anal. Calcd for C11H9Cl6N5O3 (471.94): C, 27.99; H, 1.92; N, 14.84. Found: C, 27.66; H, 1.83; N, 14.95.